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Abstract: Marine natural products have currently been recognized as the most 
promising source of bioactive substances for drug discovery research. In this 
review, extraordinary metabolites from marine algae species are illustrated, as well 
as approaches for their isolation and determination of their biological properties and 
pharmaceutical potential. Furthermore, marine endophytic microorganisms (from 
marine algae) are presented as a new subject for extensive investigation to find 
novel natural products, which make them a potentially rich and innovative source 
for new drug candidates.
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Introduction
 Over the last five decades, the study of marine 
natural products has been an intriguing and fruitful 
field for organic chemistry research. Marine organisms 
are prolific producers of structurally unique bioactive 
metabolites, including some with unusual mechanisms 
of action, besides diverse biosynthetic pathways (Costa-
Lotufo et al., 2009). The ability of some sessile benthic 
species to synthesize bioactive molecules (including 
Porifera, Cnidarians, Bryozoans, Tunicates and marine 
algae) leads to competitive benefits in an ecosystem 
characterized by extreme resource limitations and 
converts these organisms into an important source for 
pharmaceutical prospecting (McClintock & Baker, 
2001).
 The role of marine natural products in drug 
discovery began in the 1950s with the isolation of the 
nucleosides spongouridine (1) and spongothymidine 
(2) from the sponge Tectitethya crypta Laubenfels. 
These compounds inspired the synthesis of Cytarabine 
(Ara-C, 3) and Vidarabine (Ara-A, 4), anticancer 
and antiviral drugs now used for the treatment of 
acute myeloid leukemia and herpes virus infection, 
respectively (McClintock & Baker, 2001). Currently, 
a promising list of marine-derived compounds is in 
clinical trials, besides two drugs approved by the U.S. 
Food and Drug Administration and the EU: Yondelis (5) 
and Prialt (6). Ziconotide (Prialt), a peptide originally 
isolated from the venom of Conus magus Linnaeus and 
an  analogue of the N-type calcium channel blocker 
ω-conotoxin MVIIA, is used clinically for the treatment 
of patients suffering from chronic pain. Trabectedin 
(Yondelis), a tetrahydroisoquinoline alkaloid isolated 
from the ascidia Ecteinascidia turbinata Herdman, was 
approved by the UE for the treatment of advanced soft 
tissue sarcoma (Butler, 2008; Costa-Lotufo et al., 2009; 
Hill, 2011).
 In this context, the present work describes 
the main classes of compounds isolated from marine 
macroalgae, one of the first marine organisms to be 
explored for medical purposes. This report will focus 
on the most representative metabolites, considering the 
ones in clinical trials or new structures with promising 
pharmacological potential. In addition, we will present 
the intriguing metabolites isolated from endophytic 
fungi, fascinating microorganisms associated with 
marine algae, which have emerged as a new frontier for 
finding novel pharmaceutical candidates. Furthermore, 
this new productive source will be discussed on the 
basis of the unique structural characteristics responsible 
for their biological potential.
 Red algae
 Red algae (Rhodophyta, 98% marine) are 
dynamic producers of halogenated compounds, ranging 
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from peptides, polyketides, indoles, terpenes, acetogenins 
and phenols to volatile halogenated hydrocarbons (Cabrita 
et al., 2010; Fujii et al., 2011). Additionally, red algae 
synthesize large amounts of sulfated polysaccharides (cell 
wall constituents), as well as some shikimate and nucleic 
acid derivatives (Wijesekara et al., 2011; Güven et al., 
2010). A wide variety of biological activities is associated 
with marine red algae metabolites, such as antibacterial, 
antifungal, antiviral, anti-inflammatory, antiproliferative, 
antifouling, antifeedant, cytotoxic, ichthyotoxic, and 
insecticidal properties.
 Related to the marine red algae applications, 
aqueous extracts obtained from Digenea simplex 
(Wulfen) C. Agardh (Ceramiales, Rhodomelaceae) have 
been used as a vermifuge for centuries in the traditional 
medicine of East Asian countries, (Pei-Gen & Shan-
Lin, 1986). Further chemical studies were carried out, 
leading to the isolation of Kainic acid (KA), considered 
to be the main active compound in this extract. The 
anthelmintic amino acid KA (7) was later re-discovered 
as a neuroactive compound, acting in neuronal glutamate 
receptors (Hopkins et al., 2000; Sakai et al., 2005). The 
structure of KA is strictly related to other neuronal 
agonist amino acids, such as domoic acid, isolated from 
the red alga Chondria armata (Kützing) Okamura, as 
well as an anthelmintic compound (Sakai et al., 2005). 
Currently, kainoids have been used in neurobiological 
research as a standard reagent, playing an important 
role in studies of neurophysiological disorders such as 
Alzheimer, Parkinson and epilepsy (Higa & Kuniyoshi, 
2000; Smit, 2004).
 Despite medicinal use, the early investigations 
in marine natural products focused on highly 
halogenated metabolites, such as the monoterpene 
halomon (8), isolated from the red algae Portieria 
hornemanni (Lyngbye) P. C. Silva (Clardy & Walsh, 
2004; Fuller et al., 1992). Halomon exhibited selective 
cytotoxicity to brain-, renal-, and colon-tumor cell 
lines in a National Cancer Institute screening and was 
selected for preclinical drug development. Halomon (8) 
has been considered to be one of the most promising 
metabolites of marine algae; however, its progress as 
an anticancer lead has disadvantages due to its limited 
accessibility and solubility (Andrianasolo et al., 2006; 
Sotokawa et al., 2000). Another interesting bioactive 
halogenated compound from marine red algae is the 
bicyclic diterpene laurenditerpenol (9). Isolated by 
means of bioassay-guided fractionation of the lipid 
extract from Laurencia intricata J. V. Lamouroux, 
laurenditerpenol is the first marine natural product 
that inhibited the hypoxia-inducible transcription 
factor (IC50 0.4 µM); which has recently emerged as 
an key tumor-selective molecular target for anticancer 
drug development (Chittiboyina et al., 2007; Jung & 
Im, 2008; Nagle & Zhou, 2009). Moreover, Laurencia, 
belonging to the Rhodomelaceae family, is the most 
studied genus of phylum Rhodophyta and has been 
intensively investigated over the last fifty years. This 
vigorous research led to the discovery of diverse 
molecules with biological potential like the cytotoxic 
diterpene brasilenol (10) and the triterpene calicladol 
(11), and the antibacterial and cytotoxic C-15 
acetogenines, such as laurencina (12), for example. 
Recently an overview of the taxonomy and major 
bioactive secondary metabolites from the Laurencia 
complex current in Brazil was published by Fujii et al. 
(2011).
 In addition, with reference to red algae 
metabolites, there is a substantial amount of investigation 
related to the antiviral activity displayed by sulfated 
polysaccharides (Luescher-Mattli, 2003; Campo et 
al., 2009). Carrageenans (13) are the most common 
cell wall sulfo-polygalactans from Rhodophyta. The 
immunomodulatory effects of these polysaccharides 
were described as potent lectin-like T cell mitogens and 
polyclonal B cell activators (Luescher-Mattli, 2003). 
Carrageenans have been studied in the Gigartinaceae and 
Tichocarpacea families and also exhibited antioxidant, 
anticoagulant and antithrombic activities (Sokolova et 
al., 2011).
 Although there are no drugs derived from red 
algae, it is clear that this phylum represents a potential 
source of bioactive molecules that should be explored 
more thoroughly. Furthermore, recently published data 
on marine red macroalgae describes new structures 
with biological potential. In Laurencia sp. a new 
brominated diterpene, 10-acetoxyangasiol (14), was 
discovered, which exhibited potent antibacterial 
activities against the clinical bacteria Staphylococcus 
aureus, Staphylococcus sp. and Vibrio cholerae 
(Vairappan et al., 2010). One more natural product, 
(5S)-5-acetoxycaespitol (15), isolated among seven 
new halogenated metabolites from the Brazilian red 
algae Laurencia catarinensis Cordeiro-Marino & 
Fujii, demonstrated cytotoxic activity in different 
tumor cells lines (Lhullier et al., 2010). From the same 
genera, Laurencia, several compounds with fascinating 
structural diversity were recently published. This rich 
metabolite assortment is exemplified by the cytotoxic 
oxasqualenoid (16) (Cen-Pacheco et al., 2010), a new 
highly brominated aromatic compound (17) (Qin et al., 
2010), a new tricyclic brominated diterpenoid (18) with 
in vitro and in vivo anti-inflammatory activity (Chatter 
et al., 2011) and a new halogenated terpenoid (19) and 
a new C15-acetogenin containing a cyclic ether (20) 
(Abdel-Mageed et al., 2010; Gutiérrez-Cepeda et al., 
2011; Liu et al., 2010). Finally, a new bromophenol 
(21) with antioxidant activity was found in Rhodomela 
confervoides (Hudson) P. C. Silva (Li et al., 2011b), 
while lithothamnin A (22), a new and unique bastadin-
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like structure, was isolated from Lithothamnion 
fragilissimum Foslie (Wyk et al., 2011).
Brown algae
 The phylum is almost exclusively marine and 
is known for producing major metabolites derived 
from isoprene (McClintock & Baker, 2001). Besides 
the complex diterpenoids synthesized by brown 
algae, volatile compounds, fucoidans, phlorotannins 
and fucoxanthins exhibiting antioxidant, antibiotic, 
antifungal, antiviral, or anti-cancer activities have been 
reported (Folmer et al., 2010).
 The main volatile compounds produced by 
marine brown algae are cyclic or acyclic short chain 
hydrocarbons (C8 or C11), arising from enzymatic 
conversion of long chain fatty acids. These compounds 
are used as pheromones in sexual reproduction, while 
the decomposition products are employed in chemical 
defense (McClintock & Baker, 2001; Rui & Boland, 
2010). Metabolites such as dictyotene (23) have been 
isolated from varied species and are related to the 
complex sexual reproduction process in this phylum. 
However, some authors have associated the occurrence 
of these metabolites to restricted areas where there is 
a great variety of hydrocarbons due to oil pollution 
(Teixeira, 2009).
 Fucoidans are sulfated polysaccharides (24) 
that have been reported to possess antiviral activity 
against infectious diseases, such as HIV, herpes simplex 
virus types (HSV-1 and HSV-2) and cytomegalovirus 
(Wijesekara et al., 2011). A fucoidan isolated from 
Cladosiphon okamuranus Tokida (Phaeophyceae) 
demonstrated strong inhibition against dengue virus 
type two infections. The results described by Hidari 
et al. (2008) indicate that fucoidan interacts directly 
with envelope glycoprotein on the virus. Consequently, 
this compound could be a candidate for development 
of a potential inhibitory agent against the dengue virus 
(Wijesekara et al., 2011).
 Phlorotannins are tannin derivatives mainly 
isolated from brown algae, composed of several 
phloroglucinol units polymerized in different 
ways. Among all marine algae, the members of the 
Laminariaceae family are reported to be the richest 
source of phlorotannins (Thomas & Kim, 2011; 
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Wijesinghe & Jeon, 2011). These structures could 
drive the drug discovery process, since they exhibit 
antioxidant, anti-inflammatory, antidiabetic, antitumor, 
antihypertensive and anti-allergic activities (Thomas 
& Kim, 2011). Recently, the biological knowledge and 
the promising potential for cosmeceutical applications 
have been reviewed for phlorotannins, some alginates 
(25) and fucoxanthins (26) (Wijesinghe & Jeon, 2011). 
Dieckol (27) has been reported as a promising target 
for application in antiaging and whitening formulations 
due to its exceptional protective activity against photo-
oxidative stress, besides its tyrosinase inhibitory 
activity (Heo et al., 2009; Li et al., 2009).
 Recently, the isolation of a new asymmetric 
bis-diterpene dictyotadimer A (28) from the genus 
Dictyota Lamouroux was reported (Viano et al., 
2011), while at the same time antiviral diterpenes (29) 
were found in Dictyota menstrualis (Hoyt) Schetter, 
Höming & Weber-Peukert (Cavalcanti et al., 2011). 
Ayyad et al. (2011) described the new diterpene amijiol 
acetate (30) from Dictyota dichotoma (Hudson) J. V. 
Lamouroux, very interesting not only for its potent 
cytotoxicity against several different cell lines, but also 
for its antioxidant properties. New diterpenes featuring 
the 2,6-cyclo-xenicane skeleton (31) were isolated 
from Dilophus fasciola (Roth) J. V. Lamouroux and 
Dilophus spiralis (Montagne) G. Hamel (Ioannou et 
al., 2009). New brominated selinane (32) and cadinane 
(33) sesquiterpenes were reported from the genus 
Dictyopteris Lamouroux (Ji et al., 2009; Qiao et al., 
2009; Wen et al., 2009). The cytotoxic activity of new 
bisprenylated quinols (34), accumulated in Sporochnus 
comosus C Agradh, were reported by Oveden et al. 
(2011). In addition, two dolastane diterpenes  isolated 
from the Brazilian brown alga Canistrocarpus 
cervicornis (Kützing) De-Paula & De Clerck were 
described as promising antiviral compounds (Vallim 
et al., 2010), besides phlorotannins from Ecklonia 
stolonifera Okamura and Eisenia bicyclis (Kiellman) 
Stchell, which were responsible for preventing diabetes 
complications (Moon et al., 2011).
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Green algae
 The main representative substances of the 
phylum Chlorophyta are isoprenoid derivatives. 
Acetogenins, amino acid derivatives, carbohydrates 
and shikimate derivatives have also been isolated 
from these algae (McClintock & Baker, 2001). Only a 
small percentage of this phylum belongs to the marine 
environment (13%) and, consequently, they are the least 
representative macroalgae division in marine natural 
products chemistry.
 The most remarkable in terms of bioactive 
metabolites isolated from marine green algae is the 
cyclic depsipeptide kahalide F (35). Kahalide F was 
initially obtained from the herbivorous sea slug Elysia 
rufescens; however, it is assumed that the genuine 
source of this compound is the chlorophyta Bryopsis sp., 
which is the main element of the sea slug’s diet (Folmer 
et al., 2010). Kahalide F (35), developed by the Spanish 
biopharmaceutical company PharmaMar, is a novel 
antitumor drug candidate currently in phase II clinical 
trials and causes oncosis in cancer cells by lysosomal 
induction and cell membrane permeabilization (Folmer 
et al., 2010). Other metabolites isolated from green 
algae, like the diterpene halimedatrial (36) from 
Udotea ﬂabellum (J.Ellis & Solander) M. A. Howe and 
Halimeda sp. Lamouroux, besides the bromophenolic 
compound isorawsonol (37) from Avrainvillea rawsonii 
(Dickie) M. A. Howe, have demonstrated interesting 
anticancer potential (Folmer et al., 2010). Recently, a 
new sterol, 24-R-stigmasta-4,25-diene-3β,6β-diol (38), 
among another known compounds, was isolated from 
Codium divaricatum Holmes, a traditional Chinese 
medicine used as an anticancer agent since the remote 
past (He et al., 2010).
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 Endophytic marine microorganisms
 Microbial natural products are a large and 
promising area for obtaining new and potent therapeutic 
agents (Demain, 2009; Lam, 2007). Combining 
the particularities of the marine environment and 
microbial versatility, marine microorganisms have 
been considered to be the most hopeful natural source 
for drug discovery (Glaser & Mayer, 2009; Lam, 2007). 
Marine microorganisms have shown an excellent 
biosynthetic ability to generate bioactive metabolites 
(Jensen et al., 2005; Simmons et al., 2008).
 Marine fungi comprise a small group of 
ecologically well-known filamentous ascomycetes, 
yeasts and their anamorphs (Pang & Mitchell, 2005). The 
assumption regarding the strong symbiotic relationship 
between microorganisms and their invertebrate 
hosts has been increasingly solidified, since several 
studies indicate that the active substances isolated 
from sponges, sea squirts, and corals, among others, 
may actually have originated from their associated 
microorganisms (Glaser & Mayer, 2009; Simmons et 
al., 2008). Moreover, of twenty substances derived from 
(or inspired by) marine organisms that are in final trial 
for approval as new cancer treatment drugs, sixteen are 
directly related to microbial biosynthesis and five are, 
in fact, isolated from microorganisms (Simmons et al., 
2008).
 Considering the fundamental role of 
microorganisms in the invertebrate’s bioactive 
metabolite production, it is important to point out the 
relevance of the endophytism regarding macro- and 
microorganisms. Endophytic microorganisms consist 
of fungi and bacteria living at least part of their life 
cycle within the healthy tissue of their host (generally 
plants, algae or invertebrates), in a relationship that can 
diverge between latent phytopathogenesis and mutual 
symbiosis (Strobel et al., 2004; Tan & Zou, 2001).
 The complexity and importance of this 
ecological relationship are reflected in the chemical 
and biological potential of endophytes in natural 
products research. In general, the study of endophytic 
microorganisms represents a relatively new branch and, 
therefore, an unexplored field (Guo et al., 2009; Strobel 
et al., 2004). The association between algae and fungi 
has been well established; however, there are only a 
few studies with reference to metabolites isolated from 
fungi associated with marine algae inner tissues (Jones 
et al., 2008).
 Table 1 summarizes unknown compounds 
isolated from fungi derived from marine algae inner 
tissues. To obtain endophytic fungi cultures, authors 
usually make use of superficial sterilization methods 
to avoid the isolation of epiphytic microorganism. 
Analyzing the data presented, we can infer that the 
search for new metabolites from marine red algae 
endophytic fungi is quite recent, the first report being 
from the beginning of the last decade. An evident growth 
in interest in this field is justified by 33 papers dealing 
with chemical investigations of endophytic fungi from 
marine algae, more than 50% of which appeared in the 
literature after 2008.
 Related to the endophytic fungal source, 
it is clear that the fungi were isolated from the most 
representative species belonging to different macroalgae 
phylum. These algal species had already been studied, 
such as the green ones from the genera Codium 
Stackhouse and Ulva L. (including Enteromorpha Link 
in Nees), the brown algae from the genera Sargassum 
C. Agardh and Fucus, and Laurencia as the red algae 
example. In addition, there is no problem with the 
marine algae, since its role is just to serve a host for 
the endophytic microorganisms, as noted in Table 1. 
Moreover, these marine seaweed species are responsible 
for the great chemical structure diversity, besides the 
expressive biological potential.
 The metabolites derived from endophytes 
collected from marine green algae presented, in 
general, bicyclical structures with some oxygenations 
or even aromatic moieties, demonstrating cytotoxicity, 
antiprotozoa and antimicrobial activities (Elsebai 
et al., 2010; Zhu et al., 2009; El-Beih et al., 2007; 
Osterhage et al., 2000), besides fat-accumulation 
inhibitory activity (Almeida et al., 2010), modulation 
of carcinogen metabolizing enzymes and protection 
from DNA damage (Gamal-Elden et al., 2009).
 Related to substances obtained from endophytes 
associated with brown algae, we can highlight a greater 
structural and bioactivity assortment: naphto- and pyrone 
derivatives presenting antifungal and antioxidant activity 
(Zhang et al., 2010; Zhang et al., 2007a, b), macrolides 
showing antibacterial potential (Holler et al., 2000; Yang 
et al., 2006), isobenzofuranone derivative and bicyclic 
lactones (Abdel-Lattef et al., 2003; Osterhage et al., 
2002a), antioxidant benzodiazepine derivatives (Cui et 
al., 2009) and cytotoxic ergosterolide derivates with an 
unusual pentalactone B-ring (Cui et al., 2010).
 Considering red algae as the source of endophytes, 
the metabolites also presented some interesting chemical 
structure variations and biological potential. Some examples 
are the new oxylipin and steroidal acetylcholinesterase 
inhibitors (Qiao et al., 2011); curvularin-type macrolides 
presenting antibacterial, antifungal and algicide 
properties (Dai et al., 2011), several classes of terpenes 
like the antimicrobial indoloterpenes (Qiao et al., 2010), 
sesquiterpenoids with antiplasmodial activity (Osterhage 
et al., 2002b), tetracyclic diterpenes (Gao et al., 2011a) 
and one antimicrobial monoterpene (Gao et al., 2011b). 
Moreover, other interesting properties are exemplified 
by polyoxygenated compounds with antifungal potential, 
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cytotoxic steroids with tetrahydroxy and C-16-acetoxy 
groups (Gao et al., 2011c), antimicrobial and cytotoxic 
polyketides (Gao et al., 2011b), aromatic pentaketides of 
the dihydroisocoumarins class (Pontius et al., 2008a) and 
cytotoxic benzaldehyde derivatives (Wang et al., 2006).
 Finally, we point out some characteristics of 
metabolites from unidentified marine algae endophytes: 
antioxidant hydroquinone derivates (Abdel-Lattef et al., 
2002), prenylated polyketide benzophenone derivatives 
(Kralj et al., 2006), monomeric xanthones showing cancer 
chemopreventive action by inhibition of cytochrome 
P450 and other correlated enzymes (Krick et al., 2007). 
Exploring carbonylated structures, some motivating 
compounds include the dihydroisocoumarins derived from 
aromatic pentaketides (Pontius et al., 2008a), dimeric 
chromanones and some other polyketides containing 
two uniquely modified xanthone derived units, besides 
enzyme inhibitor properties (Pontius et al., 2008a,c) and 
a rubralactone derivative showing enzymatic inhibition of 
DNA polymerase (Naganuma et al., 2008).
Table 1. Unknown substances isolated from marine algae endophytic fungi.
Algae(host) Fungi(endophyte) Structures* number Reference
C
hl
or
op
hy
ta
 (g
re
en
 a
lg
ae
) Blidingia minima (Nägeli ex Kützing) Kylin Penicillium sp. 39 Zhu et al., 2009
Codium fragile (Suringar) Hariot Valsa ceratosperma (Tode ex Fries) Maire 40 El-Beih et al., 2007
Enteromorpha sp. Cadophora malorum  (Kidd & Beaumont) W. 
Gams
41-44 Almeida et al., 2010
Enteromorpha sp. Coniothyrium cereale E. Müll 45-51 Elsebai et al., 2010
Ulva sp. Ascochyta salicorniae  Magnus apud Jaap 52-54 Osterhage et al., 2000
Ulva sp. Penicillium sp. 55 Gamal-Elden et al., 2009
Valonia utricularis (Roth) C.Agardh Chaetomium sp. 56 Abdel-Lateff, 2008
Ph
ae
op
hy
ta
 (b
ro
w
n 
al
ga
e) Colpomenia sinuosa (Mertens ex Roth) Derbès & Solier
Aspergillus niger Van Tieghem 57-62 Zhang et al., 2007a,b; 
Zhang et al., 2010
Cytoseira sp. Varicosporina ramulosa Meyers et Kohlm 63, 64 Holler et al., 2000
Fucus spiralis L. Phoma tropica R. Schneid. & Boerema 65 Osterhage et al., 2002a
Fucus vesiculosus L. Epicoccum sp. 66 Abdel-Lateff et al., 2003
Sargassum sp. Not identified 67, 68 Yang et al., 2006
Sargassum kjellmanianum Yendo Aspergillus ochraceus Wilhelm 69-72 Cui et al., 2009 Cui et 
al., 2010
R
ho
do
ph
yt
a 
(r
ed
 a
lg
ae
)
Corallina officinalis L. Aspergillus ﬂavus Johann Heinrich. Friedrich 
Link
73,74 Qiao et al., 2011
Gracilaria folifera (Forsskål) Borgesen Curvularia sp. 75, 76 Dai et al., 2011
Heterosiphonia japonica Yendo Aspergillus oryzae (Ahlburg) E. Cohn 77-79 Qiao et al., 2010
Kappaphycus alvarezii  (Doty) Doty ex 
P.C.Silva
Mycelium sterillium (KT 29) 80 Tarman et al., 2011
Liagora viscida (Forsskål) C.Agardh Drechslera dematioidea (Bubak & Wroblewski) 
Subram, & Jain
81-90 Osterhage et al., 2002b
Laurencia sp. Penicillium chrysogenum Thom 91-98 Gao et al., 2011a,b,c
Laurencia similis Nam & Saito Exophialia oligosperma Calendron ex de Hoog 
& Tintelnot
99** Li et al., 2011a
Plocamium sp. Acremonium sp. 100 Pontius et al., 2008a
Polysiphonia urceolata (Lightfoot ex 
Dillwyn) Greville
Chaetomium globosum Kunze 101 Wang et al., 2006
U
nd
efi
ne
d
Acremonium sp. 102, 103 Abdel-Lateff et al., 2002
Emericella nidulans var. acristata (Fennell & 
Raper) Subram
104, 105 Kralj et al., 2006
Monodictys putredinis (Wallr.) Hughes 106-111 Krick et al., 2007; 
Pontius et al., 2008b
Nodulisporium sp. 112, 113 Pontius et al., 2008a,c
Not identified 114 Naganuma et al., 2008
*Unknown structures and unknown as natural products; **Unknown structure as fungi natural product.
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Conclusion
 Marine organisms have been the focus of 
interesting discoveries, which have led to important 
drugs actually available from the pharmaceutical 
industry, such as Ara-A, Ara-C, Yondelis and Prialt. Since 
the early studies concerning the marine environment, 
seaweeds have emerged as a vast source of unique 
structures and bioactive metabolites. Currently, an 
innovative approach that has been taken is the isolation 
of endophytic microorganisms from macroalgae, 
exploring an interesting ecological relationship. This 
new research frontier, which represents a new natural 
products source to be explored, implies that, in the 
future, the intriguing chemical structures already 
isolated from these microorganisms may provide high-
quality drug candidates to improve human health.
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